Log in

NASDAQ:LMATLeMaitre Vascular Stock Price, Forecast & News

$26.35
+0.11 (+0.42 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$25.83
Now: $26.35
$26.88
50-Day Range
$23.68
MA: $25.66
$28.22
52-Week Range
$18.76
Now: $26.35
$38.64
Volume74,186 shs
Average Volume141,407 shs
Market Capitalization$531.80 million
P/E Ratio30.29
Dividend Yield1.44%
Beta1.37
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and Reddick cholangiogram catheters to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Read More
LeMaitre Vascular logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.9Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.15 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LMAT
CUSIPN/A
Phone781-221-2266

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$117.23 million
Cash Flow$1.17 per share
Book Value$7.41 per share

Profitability

Net Income$17.93 million

Miscellaneous

EmployeesN/A
Market Cap$531.80 million
Next Earnings Date7/22/2020 (Estimated)
OptionableOptionable

Receive LMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

How has LeMaitre Vascular's stock been impacted by COVID-19 (Coronavirus)?

LeMaitre Vascular's stock was trading at $26.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LMAT stock has increased by 1.0% and is now trading at $26.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of LeMaitre Vascular?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for LeMaitre Vascular.

When is LeMaitre Vascular's next earnings date?

LeMaitre Vascular is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for LeMaitre Vascular.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular Inc (NASDAQ:LMAT) issued its quarterly earnings results on Thursday, April, 30th. The medical instruments supplier reported $0.16 earnings per share for the quarter, hitting analysts' consensus estimates of $0.16. The medical instruments supplier had revenue of $30.55 million for the quarter, compared to analyst estimates of $30.50 million. LeMaitre Vascular had a return on equity of 12.26% and a net margin of 14.75%. The company's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.17 earnings per share. View LeMaitre Vascular's earnings history.

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular declared a quarterly dividend on Monday, May 4th. Stockholders of record on Wednesday, May 20th will be given a dividend of $0.095 per share on Thursday, June 4th. This represents a $0.38 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date is Tuesday, May 19th. View LeMaitre Vascular's dividend history.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular issued an update on its first quarter earnings guidance on Monday, April, 13th. The company provided earnings per share guidance of $0.15-0.16 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.16. The company issued revenue guidance of $30.4-30.6 million, compared to the consensus revenue estimate of $30.45 million.

What price target have analysts set for LMAT?

7 equities research analysts have issued twelve-month price targets for LeMaitre Vascular's shares. Their forecasts range from $25.00 to $40.00. On average, they expect LeMaitre Vascular's share price to reach $30.71 in the next twelve months. This suggests a possible upside of 16.6% from the stock's current price. View analysts' price targets for LeMaitre Vascular.

Has LeMaitre Vascular been receiving favorable news coverage?

Press coverage about LMAT stock has trended negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. LeMaitre Vascular earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about LeMaitre Vascular.

Are investors shorting LeMaitre Vascular?

LeMaitre Vascular saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 1,540,000 shares, a decrease of 32.2% from the May 31st total of 2,270,000 shares. Based on an average daily trading volume, of 146,000 shares, the short-interest ratio is presently 10.5 days. Approximately 9.1% of the company's stock are short sold. View LeMaitre Vascular's Current Options Chain.

Who are some of LeMaitre Vascular's key competitors?

What other stocks do shareholders of LeMaitre Vascular own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include Canopy Growth (CGC), AbbVie (ABBV), Sociedad Quimica y Minera de Chile (SQM), Gilead Sciences (GILD), NVIDIA (NVDA), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Adobe (ADBE), Boeing (BA) and salesforce.com (CRM).

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the following people:
  • Mr. George W. LeMaitre, Chairman & CEO (Age 54)
  • Mr. David B. Roberts, Pres & Director (Age 55)
  • Mr. Joseph P. Pellegrino Jr., CFO, Treasurer, Sec. & Director (Age 54)
  • Mr. Trent G. Kamke, Sr. VP of Operations (Age 48)
  • Dr. George D. LeMaitre, Founder and Chairman of Scientific Advisory Board (Age 85)

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How do I buy shares of LeMaitre Vascular?

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LMAT stock can currently be purchased for approximately $26.35.

How big of a company is LeMaitre Vascular?

LeMaitre Vascular has a market capitalization of $531.80 million and generates $117.23 million in revenue each year. The medical instruments supplier earns $17.93 million in net income (profit) each year or $0.88 on an earnings per share basis.

What is LeMaitre Vascular's official website?

The official website for LeMaitre Vascular is www.lemaitre.com.

How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.